Ontology highlight
ABSTRACT:
SUBMITTER: Ludwig H
PROVIDER: S-EPMC3228121 | biostudies-other | 2011
REPOSITORIES: biostudies-other
Ludwig Heinz H Beksac Meral M Bladé Joan J Cavenagh Jamie J Cavo Michele M Delforge Michel M Dimopoulos Meletios M Drach Johannes J Einsele Hermann H Facon Thierry T Goldschmidt Hartmut H Harousseau Jean-Luc JL Hess Urs U Kropff Martin M Leal da Costa Fernando F Louw Vernon V Magen-Nativ Hila H Mendeleeva Larisa L Nahi Hareth H Plesner Torben T San-Miguel Jesús J Sonneveld Pieter P Udvardy Miklos M Sondergeld Pia P Palumbo Antonio A
The oncologist 20110326 4
The arrival of the novel agents thalidomide, bortezomib, and lenalidomide has significantly changed our approach to the management of multiple myeloma and, importantly, patient outcomes have improved. These agents have been investigated intensively in different treatment settings, providing us with data to make evidence-based decisions regarding the optimal management of patients. This review is an update to a previous summary of European treatment practices that examines new data that have been ...[more]